Nebulizers, inhalers, and spirometers for Chronic Obstructive Pulmonary Disease (COPD) and asthma- An updated review
Keywords:
Asthma, Chronic Obstructive Pulmonary Disease, Inhalation Therapy, Nebulizers, Pressurized Metered-Dose Inhalers, Dry Powder Inhalers, Patient AdherenceAbstract
Background: Asthma and chronic obstructive pulmonary disease (COPD) are prevalent chronic conditions significantly impacting healthcare costs and patient quality of life. Inhalation therapy plays a crucial role in managing these diseases, with a wide array of devices available for medication delivery. Aim: This review aims to update the understanding of nebulizers, inhalers, and spirometers in managing asthma and COPD, highlighting device usage, patient adherence, and clinical outcomes. Methods: A comprehensive literature review was conducted, focusing on the effectiveness, usability, and patient adherence associated with various inhalation devices, including nebulizers, pressurized metered-dose inhalers (pMDIs), and dry powder inhalers (DPIs). Patient preferences and common user errors were also analyzed. Results: Findings indicate a significant prevalence of incorrect inhalation techniques, which adversely affect treatment outcomes. Despite the growing market for inhalation devices, non-adherence remains a challenge, particularly among patients with cognitive impairments. User errors were common across all device types, highlighting the need for improved patient education and device selection tailored to individual capabilities. Conclusion: Optimizing inhalation techniques and enhancing patient education are essential for improving clinical outcomes in asthma and COPD management. Future strategies should focus on personalized device selection and ongoing support to foster adherence and correct usage.
Downloads
References
Lewis A Torvinen S Dekhuijzen PN The economic burden of asthma and chronic obstructive pulmonary disease and the impact of poor inhalation technique with commonly prescribed dry powder inhalers in three European countries BMC Health Serv Res20161625127406133
Asthma UK Asthma facts and statistics.
World Health Organization Chronic respiratory diseases .
Stein SW Thiel CG The history of therapeutic aerosols: a chronological reviewJ Aerosol Med Pulm Drug Deliv2017301204127748638
Lavorini FC orrigan CJ Barnes PJ Aerosol Drug Management Improvement Team Retail sales of inhalation devices in European countries: so much for a global policy Respir Med201110571099110321489771
Rogueda P Traini D The future of inhalers: how can we improve drug delivery in asthma and COPD?Expert Rev Respir Med201610101041104427545190
Braido F Chrystyn H Baiardini I Respiratory Effectiveness Group“Trying, but failing” – the role of inhaler technique and mode of delivery in respiratory medication adherenceJ Allergy Clin Immunol Pract20164582383227587316
Lavorini FF ontana G A Usmani OS New inhaler devices – the good, the bad and the uglyRespiration201488131524902629
Dudvarski Ilic A Zugic VZ vezdin B Influence of inhaler technique on asthma and COPD control: a multicenter experience Int J Chron Obstruct Pulmon Dis2016112509251727785007
Global Initiative for Asthma GINA Report: Global Strategy for Asthma Management and Prevention.
Price DB Román-Rodríguez M McQueen RB Inhaler errors in the CRITIKAL study: type, frequency, and association with asthma outcomesJ Allergy Clin Immunol Pract2017541071108128286157
Brand stetter SF inger TFi scher W Differences in medication adherence are associated with beliefs about medicines in asthma and COPDClin Transl Allergy201773929152167
Vestbo J Anderson JA Calverley PM Adherence to inhaled therapy, mortality and hospital admission in COPDThorax2009641193994319703830
Sulaiman I Cushen B Greene G Objective assessment of adherence to inhalers by patients with chronic obstructive pulmonary diseaseAm J Respir Crit Care Med2017195101333134327409253
Melani A S Bonavia M Cilenti V Gruppo Educazionale Associ-azione Italiana Pneumologi Ospedalieri Inhaler mishandling remains common in real life and is associated with reduced disease controlRespir Med2011105693093821367593
Molimard MR aherison CL ingot S Chronic obstructive pulmonary disease exacerbation and inhaler device handling: real-life assessment of 2935 patientsEur Respir J2017492160179428182569
Usmani OS Lavorini F Marshall J Critical inhaler errors in asthma and COPD: a systematic review of impact on health outcomesRespir Res20181911029338792
Press VG Arora VMShahL Teaching the use of respiratory inhalers to hospitalized patients with asthma or COPD: a randomized trialJ Gen Intern Med201227101317132522592354
Dekhuijzen PN Lavorini Fu smani OS Patients’ perspectives and preferences in the choice of inhalers: the case for Respimat(®) or Handi Haler(®)Patient Prefer Adherence2016101561157227574405
Chorão P Pereira AM Fonseca JA Inhaler devices in asthma and COPD – an assessment of inhaler technique and patient preferencesRespir Med2014108796897524873873
Inhaler Error Steering Committee PriceD Bosnic-Anticevich S Inhaler competence in asthma: common errors, barriers to use and recommended solutionsRespir Med20131071374623098685
Bonini M Usmani OS The importance of inhaler devices in the treatment of COPDCOPD Res Pract2015119
Bosnic-Anticevich SC hrystyn H Costello RW The use of multiple respiratory inhalers requiring different inhalation techniques has an adverse effect on COPD outcomesInt J Chron Obstruct Pulmon Dis201612597128053517
Price DB Colice G Israel E Add-on LABA in a separate inhaler as asthma step-up therapy versus increased dose of ICS or ICS/LABA combination inhalerERJ Open Res2016220010627730200
Lavorini FU smani OS Correct inhalation technique is critical in achieving good asthma controlPrim Care Respir J201322438538624270367
Taffet GE DonohueJ F Altman PR Considerations for managing chronic obstructive pulmonary disease in the elderlyClin Interv Aging20149233024376347
Yawn BP Colice GL Hodder R Practical aspects of inhaler use in the management of chronic obstructive pulmonary disease in the primary care settingInt J Chron Obstruct Pulmon Dis2012749550222888221
Wachtel H Kattenbeck S Dunne S The Respimat(®) development story: patient-centered innovationPulm Ther2017319
Bowles SK Sketris I Kephart G Drug Evaluation Alliance of Nova ScotiaUse of wet nebulized inhaled respiratory medications under criteria-based reimbursement guidelines in a publicly funded Seniors’ Pharmacare Program in Nova Scotia, Canada Am J Geriatr Pharmacother20075212012817719514
Cates CJ Welsh EJ RoweBH Holding chambers (spacers) versus nebulisers for beta-agonist treatment of acute asthma Cochrane Database Syst Rev20139CD000052
Loh CH Peters SP Lovings TM Ohar JA Suboptimal inspiratory flow rates are associated with chronic obstructive pulmonary disease and all cause readmissionsAnn Am Thorac Soc20171481305131128406710
Business Wire Sunovion Receives FDA Approval for Lonhala™ Magnair™ Inhalation Solution to Treat COPD.
Usmani OS Treating the small airwaysRespiration201284644145323154684
Sonnappa S McQueen B Postma DS Extrafine versus fine inhaled corticosteroids in relation to asthma control: a systematic review and meta-analysis of observational real-life studiesJ Allergy Clin Immunol Pract Epub2017920
Sonnappa S Martin R Israel E Respiratory Effectiveness Group, Small Airways Study GroupRisk of pneumonia in obstructive lung disease: a real-life study comparing extra-fine and fine-particle inhaled corticosteroidsPLoS One2017126e017811228617814
Levy MLDekhuijzen PN Barnes PJ Inhaler technique: facts and fantasies. A view from the Aerosol Drug Management Improvement Team (ADMIT)NPJ Prim Care Respir Med2016261601727098045
DalbyR NEicherJ ZierenbergB Development of Respimat(®) Soft Mist™ inhaler and its clinical utility in respiratory disordersMed Devices (Auckl)2011414515522915941
LavoriniF PistolesiM Usmani OS Recent advances in capsule-based dry powder inhaler technologyMultidiscip Respir Med2017121128536654
Muralid haran P Hayes DJr Mansour HM Dry powder inhalers in COPD, lung inflammation and pulmonary infectionsExpert Opin Drug Deliv201512694796225388926
RauJLPractical problems with aerosol therapy in COPD Respir Care200651215817216441960
Al-Showair RA Tarsin WY Assi K H Pearson SB Chrystyn HCan all patients with COPD use the correct inhalation flow with all inhalers and does training help?Respir Med2007101112395240117629471
Borgström L Asking L Lipniunas P An in vivo and in vitro comparison of two powder inhalers following storage at hot/humid conditionsJ Aerosol Med200518330431016181005
GandertonD Targeted delivery of inhaled drugs: current challenges and future goalsJ Aerosol Med199912Suppl 1S3S810623339 DOI: https://doi.org/10.1089/jam.1999.12.Suppl_1.S-3
Moroni-Zentgraf P Impact of patient needs on design and usage of an inhalation device in respiratory medicineRespir Drug Deliv20131141
Anderson P Use of Respimat Soft Mist inhaler in COPD patientsInt J Chron Obstruct Pulmon Dis20061325125918046862
Dal Negro RW Longo P Ziani OV BonadimanL Turco PInstant velocity and consistency of emitted cloud change by the different levels of canister filling with Metered Dose Inhalers (MDIs), but not with Soft Mist Inhalers (SMIs): a bench studyMultidiscip Respir Med2017121328560037
Dal NegroR W Povero M Acceptability and preference of three inhalation devices assessed by the Handling Questionnaire in asthma and COPD patientsMultidiscip Respir Med201611726865979
Brand PH ederer BA usten G Dewberry H MeyerT Higher lung deposition with Respimat Soft Mist inhaler than HFA-MDI in COPD patients with poor techniqueInt J Chron Obstruct Pulmon Dis20083476377019281091
Pedersen S Dubus JC Crompton GK ADMIT Working GroupThe ADMIT series – issues in inhalation therapy. 5) Inhaler selection in children with asthmaPrim Care Respir J201019320921620640390
Normansell R KewK M Mathioudakis A G Interventions to improve inhaler technique for people with asthma Cochrane Database Syst Rev20173CD01228628288272
Fink JB Rubin BK Problems with inhaler use: a call for improved clinician and patient educationRespir Care2005501013741375
Ari A Fink JB Guidelines for aerosol devices in infants, children and adults: which to choose, why and how to achieve effective aerosol therapy Expert Rev Respir Med20115456157221859275
Melani AS Bracci LS Rossi M Reduced peak inspiratory effort through the Diskus(®) and the Turbuhaler(®) due to mishandling is common in clinical practiceClin Drug Investig2005258543549
Kamin W Frank M Kattenbeck S Moroni-Zentgraf P Wachtel HZielen SA handling study to assess use of the Respimat(®) Soft Mist™ inhaler in children under 5 years oldJ Aerosol Med Pulm Drug Deliv201528537238125844687
Westerik JA Carter V Chrystyn H Characteristics of patients making serious inhaler errors with a dry powder inhaler and association with asthma-related events in a primary care settingJ Asthma201653332132926810934
Levy ML Hardwell A McKnight E HolmesJA sthma patients’ inability to use a pressurised metered-dose inhaler (pMDI) correctly correlates with poor asthma control as defined by the global initiative for asthma (GINA) strategy: a retrospective analysisPrim Care Respir J201322440641124042172
Hodder RPrice D Patient preferences for inhaler devices in chronic obstructive pulmonary disease: experience with Respimat Soft Mist inhalerInt J Chron Obstruct Pulmon Dis2009438139019888356
Perriello EA Sobieraj DM The Respimat Soft Mist inhaler, a novel inhaled drug delivery device Conn Med201680635936427509644
DarbàJ Ramírez G Sicras A Francoli P TorvinenSSánchez-de la Rosa R The importance of inhaler devices: the choice of inhaler device may lead to suboptimal adherence in COPD patientsInt J Chron Obstruct Pulmon Dis2015102335234526604733
Usmani OS Small-airway disease in asthma: pharmacological considerationsCurr Opin Pulm Med2015211556725415404
Scichilone NA sthma control: the right inhaler for the right patientAdv Ther201532428529225845769
Verbanck SG horbaniasl G Biddiscombe MF Inhaled aerosol distribution in human airways: a scintigraphy-guided study in a 3D printed modelJ Aerosol Med Pulm Drug Deliv201629652553327337643
Verbanck SK alsi HS Biddiscombe MF Inspiratory and expiratory aerosol deposition in the upper airwayInhal Toxicol201123210411121309663
Usmani OS Biddiscombe MF Barnes PJ Regional lung deposition and bronchodilator response as a function of beta2-agonist particle sizeAm J Respir Crit Care Med2005172121497150416192448
Small M Anderson P Vickers A Kay S Fermer S Importance of inhaler-device satisfaction in asthma treatment: real-world observations of physician-observed compliance and clinical/patient-reported outcomesAdv Ther201128320221221331556
Jahedi L Downie S R Saini B Chan HK Bosnic-Anticevich S Inhaler technique in asthma: how does it relate to patients’ preferences and attitudes toward their inhalers?J Aerosol Med Pulm Drug Deliv2017301425227676193
Miravitlles M Montero-Caballero J Richard FA cross-sectional study to assess inhalation device handling and patient satisfaction in COPDInt J Chron Obstruct Pulmon Dis20161140741527013871
Schürmann WS chmidtmann S Moroni P Massey D Qidan M Respimat Soft Mist inhaler versus hydrofl uoroalkane metered dose inhaler: patient preference and satisfactionTreat Respir Med200541536115725050
Hodder R Reese P R Slaton T Asthma patients prefer Respimat Soft Mist Inhaler to TurbuhalerInt J Chron Obstruct Pulmon Dis2009422523219554196
Lenney J Innes JA Crompton GK Inappropriate inhaler use: assessment of use and patient preference of seven inhalation devices. EDICIRespir Med200094549650010868714
Molimard M Colthorpe P Inhaler devices for chronic obstructive pulmonary disease: insights from patients and healthcare practitionersJ Aerosol Med Pulm Drug Deliv201528321922825265316
Crompton GK Barnes PJ Broeders MA erosol Drug Management Improvement TeamThe need to improve inhalation technique in Europe: a report from the Aerosol Drug Management Improvement TeamRespir Med200610091479149416495040
Published
How to Cite
Issue
Section
Copyright (c) 2019 International journal of health sciences
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Articles published in the International Journal of Health Sciences (IJHS) are available under Creative Commons Attribution Non-Commercial No Derivatives Licence (CC BY-NC-ND 4.0). Authors retain copyright in their work and grant IJHS right of first publication under CC BY-NC-ND 4.0. Users have the right to read, download, copy, distribute, print, search, or link to the full texts of articles in this journal, and to use them for any other lawful purpose.
Articles published in IJHS can be copied, communicated and shared in their published form for non-commercial purposes provided full attribution is given to the author and the journal. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
This copyright notice applies to articles published in IJHS volumes 4 onwards. Please read about the copyright notices for previous volumes under Journal History.
